Cargando…

A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours

BACKGROUND: PG545 (pixatimod) is a novel immunomodulatory agent, which has been demonstrated to stimulate innate immune responses against tumours in preclinical cancer models. METHODS: This Phase I study investigated the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dredge, Keith, Brennan, Todd V., Hammond, Edward, Lickliter, Jason D., Lin, Liwen, Bampton, Darryn, Handley, Paul, Lankesheer, Fleur, Morrish, Glynn, Yang, Yiping, Brown, Michael P., Millward, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931096/ https://www.ncbi.nlm.nih.gov/pubmed/29531325 http://dx.doi.org/10.1038/s41416-018-0006-0

Ejemplares similares

Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors
por: Hammond, Edward, et al.
Publicado: (2018)

Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues()
por: Hammond, Edward, et al.
Publicado: (2013)

Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections
por: Chhabra, Mohit, et al.
Publicado: (2022)

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction
por: Guimond, Scott E., et al.
Publicado: (2022)

PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
por: Dredge, K, et al.
Publicado: (2011)

PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model
por: Hammond, Edward, et al.
Publicado: (2012)

Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors
por: Lemech, Charlotte, et al.
Publicado: (2023)

PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
por: Ray, Upasana, et al.
Publicado: (2023)

The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
por: Jung, Deok-Beom, et al.
Publicado: (2014)

Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
por: Jung, Deok-Beom, et al.
Publicado: (2019)

Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545
por: Abassi, Zaid, et al.
Publicado: (2017)

Dataset on mice body weights and food intake following treatment with PG545
por: Kinaneh, Safa, et al.
Publicado: (2018)

The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression()
por: Singh, Preeti, et al.
Publicado: (2017)

The Heparan Sulfate Mimetic PG545 Modulates T Cell Responses and Prevents Delayed-Type Hypersensitivity
por: Koliesnik, Ievgen O., et al.
Publicado: (2020)

PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice
por: Supramaniam, Aroon, et al.
Publicado: (2019)

Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer
por: Deng, Jingyu, et al.
Publicado: (2015)

Protective Role of the PG1036-PG1037-PG1038 Operon in Oxidative Stress in Porphyromonas gingivalis W83
por: Henry, Leroy G., et al.
Publicado: (2013)

Klaviersonaten, KV 310, KV 333, KV 545
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1989)

Plug-In coaxial cable tester for Tektronix 545 oscilloscopes
por: Sharp, J B
Publicado: (1960)

SAT545 Erythropoietic Thyroid Nodule in the Setting of Myelofibrosis
por: Vasquez, Libia M, et al.
Publicado: (2023)

PG Convention – Report
por: Bhuvaneswaran, Mohan
Publicado: (2014)

A COMPARATIVE STUDY OF MMPI PROFILES OF PSYCHIATRIC PG's v/s MEDICAL PG's
por: Deshmukh, D. K., et al.
Publicado: (1980)

Microfocusing at the PG1 beamline at FLASH
por: Dziarzhytski, Siarhei, et al.
Publicado: (2016)

Measuring hepatitis B pgRNA stability using an updated automated HBV pgRNA assay with increased sensitivity
por: Anderson, Mark, et al.
Publicado: (2023)

Partial Lipodystrophy and LMNA p.R545H Variant
por: Magno, Silvia, et al.
Publicado: (2021)

Correction to Lancet Respir Med 2022; 10: 545–56
Publicado: (2022)

545 “After The Fire: Legacy of A College Dormitory Fire Twenty Years Later"
por: Conlon, Kathe M, et al.
Publicado: (2022)

PgMP Exam Challenge!
por: Levin, Ginger, et al.
Publicado: (2016)

Ayurvedic PG education and Panchakarma
por: Rastogi, Sanjeev
Publicado: (2013)

PG quiz: STD and pregnancy!
por: Baxi, Reema Rajesh, et al.
Publicado: (2017)

Sonate für Flöte und Cembalo Es-dur, BWV 1031 / H 545 = Sonata for flute and harpsichord in E flat major, BWV 1031 / H 545 /

PgMP practice test questions: 1000+ practice exam questions for the PgMP examination
por: Levin, Ginger
Publicado: (2018)

PgMYB1 Positively Regulates Anthocyanin Accumulation by Activating PgGSTF6 in Pomegranate
por: Wang, Zenghui, et al.
Publicado: (2023)

Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
por: Lickliter, Jason D., et al.
Publicado: (2021)

(−)(545)-fac-Δ-Tris(l-prolinato)cobalt(III) trihydrate
por: Kato, Masaru, et al.
Publicado: (2008)

Correction to Lancet Glob Health 2020; 8: e545–54
Publicado: (2020)

Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
por: Lickliter, Jason D., et al.
Publicado: (2021)

Sixteenth IACDE PG convention report
por: Taneja, Sonali
Publicado: (2015)

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
por: Dredge, K, et al.
Publicado: (2002)

Structural comparison of somatically related PG9 and PG16 in complex with their epitope reveals differences in glycan recognition
por: Pancera, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uefsss2bllfr2dc7jm10o51h4o